Melissa Hadley Barrett discusses real-world outcomes and tolerability of intranasal vardenafil for men with persistent erectile dysfunction despite prior standard therapy.
|Podcasts|October 28, 2020
Speaking of Urology: Dr. Ranjith Ramasamy discusses nasal testosterone gel and sperm parameters
Author(s)Urology Times staff
Ramasamy talks about the findings of a recent study published in the Journal of Urology.
Advertisement
This episode's guest is Ranjith Ramasamy, MD. He discusses findings from the recent Journal of Urology paper, Effect of Natesto on Reproductive Hormones, Semen Parameters, and Hypogonadal Symptoms: A Single Center, Open Label, Single Arm Trial. Ramasamy is director of male reproductive medicine and surgery and associate professor of urology at the University of Miami Miller School of Medicine.
Advertisement
Related to this article
Juan J. Andino, MD, MBA, discusses surgical decision-making in prolonged ischemic priapism and how ischemia duration affects erectile dysfunction risk and treatment timing.
Abraham Morgentaler, MD, reviews evidence showing no association between testosterone therapy and prostate cancer risk and explains the saturation model of androgen action.
Peter Clark, MD, discusses key updates to NMIBC guidelines, including revisions to risk stratification, the emerging role of biomarkers, and how to navigate treatment options for BCG-unresponsive disease.
Heather Florio joins to discuss the potential role of supplements in pelvic and sexual health.
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves nogapendekin alfa inbakicept plus BCG for papillary-only BCG-unresponsive NMIBC
2
Study compares PSMA-PET radiopharmaceuticals in prostate cancer recurrence
3
Matching mCSPC treatment to the patient, not just the trial data
4
Urocross Expander System enters US commercial use for symptomatic BPH
5